Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) Operating Expenses (2020 - 2026)

BioScience Health Innovations has reported Operating Expenses over the past 7 years, most recently at $715503.0 for Q1 2026.

  • Quarterly Operating Expenses rose 52.45% to $715503.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Mar 2026, up 97.27% year-over-year, with the annual reading at $2.5 million for FY2025, 106.37% up from the prior year.
  • Operating Expenses was $715503.0 for Q1 2026 at BioScience Health Innovations, down from $728532.0 in the prior quarter.
  • Over five years, Operating Expenses peaked at $728532.0 in Q4 2025 and troughed at $26240.0 in Q1 2022.
  • The 5-year median for Operating Expenses is $281515.5 (2023), against an average of $331125.3.
  • Year-over-year, Operating Expenses surged 1392.18% in 2022 and then rose 19.7% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $28917.0 in 2022, then soared by 850.61% to $274887.0 in 2023, then increased by 19.7% to $329052.0 in 2024, then soared by 121.4% to $728532.0 in 2025, then fell by 1.79% to $715503.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Operating Expenses are $715503.0 (Q1 2026), $728532.0 (Q4 2025), and $707013.0 (Q3 2025).